Prostatic Neoplasms: all 6,484 studies
Page 59 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Dyadic Coping in Breast and Prostate Cancer Patients and Their SpousesStatus unknownNCT00536055
- Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154CompletedNCT00535834
- Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate CancerCompletedNCT00534196
- Brachytherapy for Prostatic Carcinoma PatientsActive, not recruitingNCT00525720Phase 2
- A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate CancerTerminatedNCT00525408Phase 2
- Early Detection of Prostate Cancer by FACSStatus unknownNCT00524823
- Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNtsCompletedNCT00523484
- Blood Test to Measure DNA Damage in BloodTerminatedNCT00523471
- Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate CancerTerminatedNCT00521781Phase 2
- Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate CancerTerminatedNCT00521274Phase 2
- Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate CancerCompletedNCT00520052Not applicable
- AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate CancerCompletedNCT00519233Phase 1
- CHESS: Human and Computer Mentors for Prostate Cancer PatientsCompletedNCT00516256Not applicable
- An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid TumorsCompletedNCT00514267Phase 1/2
- Vaccine Therapy in Treating Patients With Stage D0 Prostate CancerStatus unknownNCT00514072Phase 2
- Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a ProstatectomyCompletedNCT00513721
- Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate CancerTerminatedNCT00512668Phase 1
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
- Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical ProstatectomyCompletedNCT00511498Not applicable
- Ambulatory Cancer Pain Management: A Feasibility StudyCompletedNCT00507351
- Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their PartnersStatus unknownNCT00503646Not applicable
- Multicentric Study Comparing Carcinological and Functional Results of SurgeryStatus unknownNCT00502723Phase 3
- Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate CancerCompletedNCT00502164Phase 1
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation TherapyCompletedNCT00499421
- The Effect of Radiation on Semen Quality and Fertility in Men With Prostate CancerCompletedNCT00496249
- High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate CancerCompletedNCT00494546Phase 3
- Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate CancerTerminatedNCT00494338Phase 2
- I-125 Versus Pd-103 for Low Risk Prostate CancerStatus unknownNCT00494039Phase 3
- Safety of LBH589 Alone and in Combination With IV Docetaxel and PrednisoneTerminatedNCT00493766Phase 1
- Active Surveillance in Prostate CancerCompletedNCT00490763
- Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate CancerCompletedNCT00489905Not applicable
- Study of Quality of Life for Prostate Proton TherapyStatus unknownNCT00489814
- A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate CancerCompletedNCT00489060Phase 3
- I-125 Versus Pd-103 for Medium Risk Prostate CancerStatus unknownNCT00486499Phase 3
- Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their PartnersCompletedNCT00483678Not applicable
- Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate CancerCompletedNCT00482807Phase 1
- Calcitriol or Placebo in Men for Prostate Cancer Active SurveillanceWithdrawnNCT00482157Not applicable
- A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical RecurrenceTerminatedNCT00480623Phase 1
- A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate CancerCompletedNCT00480090Phase 2
- A Phase II Trial of TPI 287 in Patients With Metastatic Prostate CancerTerminatedNCT00479635Phase 2
- ABI-008 Trial in Patients With Hormone-refractory Prostate CancerCompletedNCT00477529Phase 1/2
- OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
- 3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of ProstateTerminatedNCT00464724Not applicable
- A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate CancerCompletedNCT00459654Phase 2
- Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateCompletedNCT00459407Phase 1
- Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or SurgeryTerminatedNCT00458549Not applicable
- Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate CancerCompletedNCT00456144
- Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate CancerCompletedNCT00455624
- Cancer Prevention and Treatment Demonstration for Ethnic and Racial MinoritiesCompletedNCT00453661
- The ELDORADO (Eligard®, Docetaxel and Radiotherapy) StudyStatus unknownNCT00452556Phase 2
- Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)TerminatedNCT00450970Phase 3
- Lycopene in Healthy Male ParticipantsCompletedNCT00450957Phase 1
- Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate CancerCompletedNCT00450229Phase 1
- Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerTerminatedNCT00450008Phase 2
- A Study of Picoplatin and Docetaxel in Subjects With Prostate CancerStatus unknownNCT00448734Phase 1/2
- MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate CancerCompletedNCT00448695Phase 1
- Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate CancerCompletedNCT00448409Phase 2
- Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before ProstatectomyTerminatedNCT00448097Phase 2
- Prostatectomy Prospective DatabaseTerminatedNCT00447616
- Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerTerminatedNCT00447473Phase 2
- Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene ExpressionCompletedNCT00446901Not applicable
- Efficacy and Safety Study of Xyotax to Treat Prostate CancerCompletedNCT00446836Phase 2
- Urology Database for Outcomes ResearchCompletedNCT00444730
- Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)TerminatedNCT00444639Phase 2
- Outcomes Comparison of Robotic, Retropubic, and Perineal ProstatectomyCompletedNCT00442000
- Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate CancerStatus unknownNCT00441571Phase 1
- Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate BiopsyCompletedNCT00441532Not applicable
- Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical RadiotherapyCompletedNCT00439751Phase 3
- Taxotere Prostate Cancer New Indication Registration Trial in ChinaCompletedNCT00436839Phase 3
- Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone MetastasesCompletedNCT00434447Phase 4
- Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone MetastasesCompletedNCT00434317Phase 4
- Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer PatientsCompletedNCT00433797Phase 1/2
- Image Guided Radiation Therapy For Prostate CancerCompletedNCT00433706Phase 3
- Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
- T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsCompletedNCT00433407Not applicable
- 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of ProstateTerminatedNCT00429338Not applicable
- Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate CancerCompletedNCT00426777Phase 3
- Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerCompletedNCT00423475Phase 3
- Local Anesthesia for Prostate BiopsyCompletedNCT00422708Phase 4
- Acupuncture Treatment for Hot Flashes StudyCompletedNCT00421902Not applicable
- Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With BicalutamideCompletedNCT00421694Phase 2/3
- Active Surveillance for Prostate Cancer With Indolent FeaturesStatus unknownNCT00421265
- Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and PrednisoneTerminatedNCT00419536Phase 1
- Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant TherapyCompletedNCT00418080Phase 2
- Collection of Patient-Reported Symptoms and Performance Status Via the InternetCompletedNCT00417040Not applicable
- Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00416533Phase 2
- Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic HyperplasiaCompletedNCT00416390Not applicable
- Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate CancerCompletedNCT00416325Phase 1
- ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerCompletedNCT00415779Phase 1
- Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate CancerTerminatedNCT00415246Phase 3
- Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer PatientsStatus unknownNCT00411853Phase 2
- Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate CancerCompletedNCT00411528Phase 2
- Intensity Modulated Versus Interstitial - Radiation TherapyStatus unknownNCT00407875Not applicable
- Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel ChemotherapyCompletedNCT00407251Phase 2
- Vector Delivery of the IL-12 Gene in Men With Prostate CancerCompletedNCT00406939Phase 1
- Study of ATN-224 in Patients With Prostate CancerStatus unknownNCT00405574Phase 2
- Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic CancerCompletedNCT00405210Phase 1
- Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate CancerCompletedNCT00403221Phase 1
- Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyCompletedNCT00403000Phase 2